Janssen to Present Study with BuzzBack at the 2019 ISOQOL Annual Conference

Janssen Pharmaceuticals with be presenting their study, Non-small cell lung cancer: Insights into patient and caregiver experiences at the 26th Annual ISOQOL Conference. Done in partnership with BuzzBack Market Research, the study provides an in-depth, comprehensive understanding of the lives and experiences of patients with Stage III/IV NSCLC along with their caregivers. The poster will be presented from 3:35 - 4:15 pm on Tuesday, October 22 during the Tuesday Poster Session II for General Cancer. This year's conference will take place from October 20-23, 2019 in San Diego, CA, and carries the theme of Assessment, Action, and Accountability: Achieving optimal patient-centered outcomes through quality of life research. If you are attending, be sure to stop by the Grande Ballroom C, ground level to view the poster.

Subscribe to email updates